Cargando…
Chondroitin Sulfate Prevents STZ Induced Diabetic Osteoporosis through Decreasing Blood Glucose, AntiOxidative Stress, Anti-Inflammation and OPG/RANKL Expression Regulation
Chondroitin sulfate (CS) has antioxidative, anti-inflammatory, anti-osteoarthritic and hypoglycemic effects. However, whether it has antidiabetic osteoporosis effects has not been reported. Therefore, in this study, we established a STZ-induced diabetic rat model; CS (500 mg kg(−1) d(−1)) was orally...
Autores principales: | Zheng, Hong Xing, Chen, De Jing, Zu, Yue Xin, Wang, En Zhu, Qi, Shan Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432814/ https://www.ncbi.nlm.nih.gov/pubmed/32722636 http://dx.doi.org/10.3390/ijms21155303 |
Ejemplares similares
-
Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism
por: Qi, Shan Shan, et al.
Publicado: (2021) -
Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis
por: Bai, Peng, et al.
Publicado: (2011) -
Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis
por: Wang, Peng, et al.
Publicado: (2018) -
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010) -
Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis
por: Abdi, Saba, et al.
Publicado: (2021)